Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 2 (1)
P 4 (1)

Trial Status

Recruiting3
Enrolling By Invitation1
Not Yet Recruiting1
Unknown1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07561528Phase 4Recruiting

Electrophysiological Biomarkers and Treatment Response to Accelerated Transcranial Magnetic Stimulation in Patients With Obsessive-Compulsive Disorder

NCT07488429Not ApplicableRecruiting

Impact of rTMS Combined With Neurorehabilitation on Lower Extremity Motor Function and Spasticity in Children With Spastic Diplegic Cerebral Palsy

NCT07176091Not ApplicableEnrolling By Invitation

Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease

NCT06949423Not ApplicableNot Yet Recruiting

Assessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder

NCT06691490Not ApplicableRecruiting

The Relationships Between Neural Correlates of Effort Perception and Physical Activity Engagement

NCT01259362Phase 2Unknown

Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients

Showing all 6 trials

Research Network

Activity Timeline